• Regulations for early phase studies
• Labeling strategies for nuclear or fluorescent imaging
• Phase 0 vs Phase 1
• Study designs
• GLP vs GMP material
• What preclinical toxicity studies are needed
• Estimation of study budget and timelines
We use cookies to optimize your experience and analyze traffic on our website. By clicking 'Accept all,' you consent to the use of all cookies. You can customize your preferences by clicking on 'Settings' or read our privacy policy for more information.
These cookies make sure the website functions properly. These cookies also provide us to anonymously monitor website statistics. Because these cookies are essential for the website, you can not disable them without compromising the functionality of the website.
These cookies collect data that we use to understand how our website is used and perceived. These cookies also help us to optimize the website for the best user experience.
These cookies allow ad-networks to monitor your online behaviour so they can display relevant ads based on your interest and online behaviour. These cookies also prevent the same ads from being displayed over and over.
